Portfolio (Quarterly)
Guide ↗
Spruce Street Capital LP
· CIK 0002050194| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | KINIKSA PHARMACEUTICALS INTL | — | 918,070.0 | $58.7M | 11.52% | NEW | — | $63.95 | — |
| 2 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 2,984,125.0 | $55.8M | 10.95% | NEW | — | $18.71 | -1.2% |
| 3 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 1,376,159.0 | $44.7M | 8.76% | NEW | — | $32.45 | +14.9% |
| 4 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 6,391,328.0 | $44.2M | 8.68% | NEW | — | $6.92 | -47.1% |
| 5 | ANRO | ALTO NEUROSCIENCE INC | Healthcare | 1,353,047.0 | $35.7M | 7.01% | NEW | — | $26.39 | -4.1% |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 354,816.0 | $34.6M | 6.79% | NEW | — | $97.48 | -9.4% |
| 7 | ALKS | ALKERMES PLC | Healthcare | 543,876.0 | $28.5M | 5.59% | NEW | — | $52.40 | -22.6% |
| 8 | SVRA | SAVARA INC | Healthcare | 3,452,576.0 | $21.3M | 4.17% | NEW | — | $6.16 | -18.0% |
| 9 | PCVX | VAXCYTE INC | Healthcare | 306,047.0 | $17.8M | 3.49% | NEW | — | $58.13 | -3.6% |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 329,006.0 | $16.7M | 3.28% | NEW | — | $50.75 | -8.9% |
| 11 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 1,088,731.0 | $15.9M | 3.11% | NEW | — | $14.58 | -11.9% |
| 12 | CATX | PERSPECTIVE THERAPEUTICS INC | Healthcare | 3,693,931.0 | $12.6M | 2.47% | NEW | — | $3.41 | -20.2% |
| 13 | IFRX | INFLARX NV | Healthcare | 5,352,198.0 | $12.0M | 2.35% | NEW | — | $2.24 | -23.7% |
| 14 | — | SURROZEN INC | — | 432,040.0 | $11.2M | 2.20% | NEW | — | $25.95 | — |
| 15 | ALMS | ALUMIS INC | Healthcare | 392,574.0 | $11.0M | 2.17% | NEW | — | $28.14 | -74.4% |
| 16 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 4,059,054.0 | $9.9M | 1.95% | NEW | — | $2.45 | -34.3% |
| 17 | NERV | MINERVA NEUROSCIENCES INC | Healthcare | 1,655,500.0 | $9.2M | 1.80% | NEW | — | $5.55 | -41.8% |
| 18 | — | SAB BIOTHERAPEUTICS INC | — | 2,198,502.0 | $8.6M | 1.68% | NEW | — | $3.90 | — |
| 19 | ANTX | AN2 THERAPEUTICS INC | Healthcare | 1,661,073.0 | $8.0M | 1.58% | NEW | — | $4.84 | +16.1% |
| 20 | ERAS | ERASCA INC | Healthcare | 422,543.0 | $7.7M | 1.52% | NEW | — | $18.32 | -20.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.7%
Financial Services
1.3%